BeyondSpring Inc. Increase (Decrease) in Contract with Customer, Liability
BeyondSpring Inc. (BYSI) reported Increase (Decrease) in Contract with Customer, Liability of -$1.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-14
- BeyondSpring Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$500.00K.
- BeyondSpring Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$500.00K.
- BeyondSpring Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$500.00K.
- BeyondSpring Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was -$501.00K.
- BeyondSpring Inc. increase (decrease) in contract with customer, liability for fiscal 2025 was -$2.00M.
- BeyondSpring Inc. increase (decrease) in contract with customer, liability for fiscal 2024 was -$1.00M, a 502.01% decline from fiscal 2023.
- BeyondSpring Inc. increase (decrease) in contract with customer, liability for fiscal 2023 was $249.00K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.00M 10-Q · filed 2026-08-14 | -$1.50M derived: sum of 3 quarters · filed 2026-08-14 | -$2.00M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$500.00K 10-Q · filed 2026-05-13 | -$1.00M derived: sum of 2 quarters · filed 2026-05-13 | -$1.50M derived: sum of 3 quarters · filed 2026-05-13 | -$2.00M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$1.00M derived: sum of 2 quarters · filed 2026-03-25 | -$1.50M derived: sum of 3 quarters · filed 2026-08-14 | -$2.00M 10-K · filed 2026-03-25 |
| 2025-09-30 | -$501.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.00M derived: sum of 2 quarters · filed 2026-08-14 | -$1.50M 10-Q · filed 2025-11-12 | -$2.00M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.00M 10-Q · filed 2026-08-14 | -$1.50M derived: sum of 3 quarters · filed 2026-08-14 | -$2.00M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$500.00K 10-Q · filed 2026-05-13 | -$1.00M derived: sum of 2 quarters · filed 2026-05-13 | -$1.50M derived: sum of 3 quarters · filed 2026-05-13 | -$2.00M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$1.00M derived: sum of 2 quarters · filed 2026-03-25 | -$1.50M derived: sum of 3 quarters · filed 2026-03-25 | -$1.00M 10-K · filed 2026-03-25 |
| 2024-09-30 | -$501.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.00M derived: sum of 2 quarters · filed 2025-11-12 | -$501.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $500.00K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $249.00K 10-K · filed 2025-03-27 | |||
| 2022-12-31 | -$1.35M 20-F · filed 2023-04-18 | |||
| 2021-12-31 | $7.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $30.71M derived: sum of 2 quarters · filed 2023-04-18 | $30.37M derived: sum of 3 quarters · filed 2023-04-18 | $30.03M 20-F · filed 2023-04-18 |
| 2021-09-30 | $30.70M derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30 | $30.36M derived: sum of 2 quarters · filed 2021-12-30 | $30.03M 6-K · filed 2021-12-30 | $39.30M derived: sum of 4 quarters · filed 2023-04-18 |
| 2021-06-30 | -$338.00K derived: 6-K 6 month − 6-K 3 month · filed 2021-09-10 | -$676.00K 6-K · filed 2021-09-10 | $8.60M derived: sum of 3 quarters · filed 2023-04-18 | $8.60M derived: sum of 4 quarters · filed 2023-04-18 |
| 2021-03-31 | -$338.00K 6-K · filed 2021-06-16 | $8.94M derived: sum of 2 quarters · filed 2023-04-18 | $8.94M derived: sum of 3 quarters · filed 2023-04-18 | |
| 2020-12-31 | $9.28M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $9.28M derived: sum of 2 quarters · filed 2023-04-18 | $9.28M 20-F · filed 2023-04-18 | |
| 2020-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30 | $0.00 6-K · filed 2021-12-30 | ||
| 2020-06-30 | $0.00 6-K · filed 2021-09-10 | |||
| 2019-12-31 | $0.00 20-F · filed 2022-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |